Patents Assigned to Arrow International Limited
  • Publication number: 20140220128
    Abstract: A solid dosage form comprises coated particles of bisphosphonate or a pharmaceutically acceptable analogue or derivative thereof.
    Type: Application
    Filed: April 14, 2014
    Publication date: August 7, 2014
    Applicant: Arrow International Limited
    Inventors: Peter Persicaner, Judy Craig
  • Patent number: 8697124
    Abstract: A solid dosage form comprises coated particles of bisphosphonate or a pharmaceutically acceptable analogue or derivative thereof.
    Type: Grant
    Filed: August 24, 2007
    Date of Patent: April 15, 2014
    Assignee: Arrow International Limited
    Inventors: Peter Persicaner, Craig Judy
  • Patent number: 8440712
    Abstract: Crystalline sodium atorvastatin, compositions containing the same and methods for the production thereof.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: May 14, 2013
    Assignees: Arrow International Limited, Zhejiang Neo-Dankong Pharmaceutical Co. Ltd.
    Inventors: Kailan Zhou, Hong Liu, Zhirong Chen, Huabin Hong, Yang Sun, Yunde Wang, Jiangchun Pan
  • Patent number: 8329922
    Abstract: Crystalline sodium atorvastatin, compositions containing the same and methods for the production thereof.
    Type: Grant
    Filed: December 13, 2011
    Date of Patent: December 11, 2012
    Assignee: Arrow International Limited
    Inventors: Kailan Zhou, Hong Liu, Zhirong Chen, Huabin Hong, Yang Sun, Yunde Wang, Jiangchun Pan
  • Publication number: 20120095072
    Abstract: Crystalline sodium atorvastatin, compositions containing the same and methods for the production thereof.
    Type: Application
    Filed: December 13, 2011
    Publication date: April 19, 2012
    Applicants: ZHEJIANG NEO-DANKONG PHARMACEUTICAL CO. LTD., ARROW INTERNATIONAL LIMITED
    Inventors: Kailan ZHOU, Hong LIU, Zhirong CHEN, Huabin HONG, Yang SUN, Yunde WANG, Jiangchun PAN
  • Patent number: 8097734
    Abstract: Crystalline sodium atorvastatin, compositions containing the same and methods for the production thereof.
    Type: Grant
    Filed: August 15, 2006
    Date of Patent: January 17, 2012
    Assignees: Arrow International Limited, Zhejiang Neo-Dankong Pharmaceutical Co. Ltd.
    Inventors: Kailan Zhou, Hong Liu, Zhirong Chen, Huabin Hong, Yang Sun, Yunde Wang, Jiangchun Pan
  • Patent number: 8093407
    Abstract: Crystalline duloxetine hydrochloride, compositions containing the same and methods for the production thereof.
    Type: Grant
    Filed: September 10, 2010
    Date of Patent: January 10, 2012
    Assignees: Arrow International Limited, Chongqing Shenghuaxi Pharmaceutical Co. Ltd
    Inventors: Wei Ping Jiang, Chun Rong Jia
  • Publication number: 20110262540
    Abstract: A solid pharmaceutical composition of exemestane, in particular for oral use and treatment of cancer, comprises micronized exemestane and anti-oxidant in a film-coated tablet.
    Type: Application
    Filed: July 27, 2009
    Publication date: October 27, 2011
    Applicant: ARROW INTERNATIONAL LIMITED
    Inventors: Peter Henry Robert Persicaner, Rahul Sareen
  • Patent number: 8017647
    Abstract: Crystalline sodium atorvastatin, compositions containing the same and methods for the production thereof.
    Type: Grant
    Filed: August 15, 2006
    Date of Patent: September 13, 2011
    Assignees: Arrow International Limited, Zhejiang Neo-Dankong Pharmaceutical Co. Ltd.
    Inventors: Kailan Zhou, Hong Liu, Zhirong Chen, Huabin Hong, Yang Sun, Yunde Wang, Jiangchun Pan
  • Publication number: 20110218228
    Abstract: Crystalline sodium atorvastatin, compositions containing the same and methods for the production thereof.
    Type: Application
    Filed: May 20, 2011
    Publication date: September 8, 2011
    Applicant: ARROW INTERNATIONAL LIMITED
    Inventors: Kailan Zhou, Hong Liu, Zhirong Chen, Huabin Hong, Yang Sun, Yunde Wang, Jiangchun Pan
  • Publication number: 20100331388
    Abstract: Crystalline duloxetine hydrochloride, compositions containing the same and methods for the production thereof.
    Type: Application
    Filed: September 10, 2010
    Publication date: December 30, 2010
    Applicants: CHONGQING SHENGHUAXI PHARMACEUTICALS CO. LTD, ARROW INTERNATIONAL LIMITED
    Inventors: Wei Ping Jiang, Chun Rong Jia
  • Patent number: 7799935
    Abstract: Crystalline duloxetine hydrochloride, compositions containing the same and methods for the production thereof.
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: September 21, 2010
    Assignees: Chongqing Shenghuaxi Pharmaceuticals Co. Ltd., Arrow International Limited
    Inventors: Wei Ping Jiang, Chun Rong Jia
  • Patent number: 7795454
    Abstract: Crystalline duloxetine hydrochloride, compositions containing the same and methods for the production thereof.
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: September 14, 2010
    Assignees: Chongqing Shenghuaxi Pharmaceuticals Co. Ltd., Arrow International Limited
    Inventors: Wei Ping Jiang, Chun Rong Jia
  • Patent number: 7795455
    Abstract: Crystalline duloxetine hydrochloride, compositions containing the same and methods for the production thereof.
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: September 14, 2010
    Assignees: Chongqing Shenghuaxi Pharmaceuticals Co. Ltd., Arrow International Limited
    Inventors: Wei Ping Jiang, Chun Rong Jia
  • Publication number: 20090317460
    Abstract: A solid dosage form comprises coated particles of bisphosphonate or a pharmaceutically acceptable analogue or derivative thereof.
    Type: Application
    Filed: August 24, 2007
    Publication date: December 24, 2009
    Applicant: Arrow International Limited
    Inventors: Peter Persicaner, Craig Judy
  • Patent number: 7601835
    Abstract: Purine derivatives of formula I, substituted at the 9-position, are prepared from a chloro substituted purine starting material, first making an alkyl substitution at the 9-position, then forming the desired esterified side chain, reducing this and hydrogenating the resultant diol prior to addition of alkyl carbonyl groups.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: October 13, 2009
    Assignee: Arrow International Limited
    Inventors: Liang He, Weiping Jiang
  • Publication number: 20080021091
    Abstract: Crystalline duloxetine hydrochloride, compositions containing the same and methods for the production thereof.
    Type: Application
    Filed: June 22, 2007
    Publication date: January 24, 2008
    Applicants: Arrow International Limited, Chongqing Shenghuaxi Pharmaceutical Co. Ltd.
    Inventors: Wei Jiang, Chun Jia
  • Publication number: 20080021090
    Abstract: Crystalline duloxetine hydrochloride, compositions containing the same and methods for the production thereof.
    Type: Application
    Filed: June 22, 2007
    Publication date: January 24, 2008
    Applicants: Arrow International Limited, Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
    Inventors: Wei Jiang, Chun Jia
  • Publication number: 20080021089
    Abstract: Crystalline duloxetine hydrochloride, compositions containing the same and methods for the production thereof.
    Type: Application
    Filed: June 22, 2007
    Publication date: January 24, 2008
    Applicants: Arrow International Limited, Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
    Inventors: Wei Jiang, Chun Jia
  • Publication number: 20060264629
    Abstract: Purine derivatives, substituted at the 9-position, are prepared from a chloro substituted purine starting material, first making an alkyl substitution at the 9-position, then forming the desired esterified side chain, reducing this and hydrogenating the resultant diol prior to addition of alkyl carbonyl groups.
    Type: Application
    Filed: November 10, 2005
    Publication date: November 23, 2006
    Applicants: Arrow International Limited, Chongqing Shenghuaxi Pharmaceutical Co. Ltd.
    Inventors: Liang He, Weiping Jiang